Abstract
Key points The prognosis of patients undergoing percutaneous coronary intervention can be informed by attentive appraisal of bleeding risk and peripheral artery disease. While the predictive interplay between bleeding risk and peripheral artery disease is quite complex, the former prognostic factor seems more potent and capable of better guiding decision‐making. Future research is warranted to gauge the benefits of individualized antithrombotic and antiatherosclerotic regimens to improve long‐term prognosis in patients undergoing percutaneous coronary intervention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
